Jointown Pharmaceutical Group Co., Ltd. is a comprehensive pharmaceutical company based in China. It primarily engages in the distribution and wholesale of pharmaceutical products, including active pharmaceutical ingredients, biological drugs, and traditional Chinese medicine. The company's core function is to bridge the gap between pharmaceutical manufacturers and end-users, such as hospitals, clinics, and retail pharmacies. Jointown stands out in the industry by leveraging advanced logistics and distribution networks that ensure the timely delivery of healthcare products across various regions. Its operations are crucial in the healthcare supply chain, impacting both urban and rural healthcare facilities by enhancing access to essential medicines. As one of the largest pharmaceutical distribution firms in China, Jointown plays a pivotal role in ensuring the efficiency and reliability of drug delivery systems. Reflecting the rapid growth and development in China's healthcare sector, the company contributes significantly to public health by facilitating widespread distribution and availability of quality pharmaceuticals.
Industry
Medical Distribution
Healthcare sector · China
Stories
Structural patterns identified in Jointown Pharmaceutical Group Co., Ltd.
No stories identified yet.
Key Metrics
Market Capitalization
26.57BCNY
NormalMar 19, 2026
Trailing P/E
9.58CNY
NormalMar 19, 2026
Revenue (TTM)
157.71BCNY
NormalMar 19, 2026
Profit Margin
1.77%
NormalMar 19, 2026
Beta
0.3260CNY
NormalMar 19, 2026
52-Week Change
2.29CNY
ExtremeMar 19, 2026
Forward Annual Dividend Yield
3.75%
NormalMar 19, 2026
Forward Yield
3.75%
Annual Rate
CNY 0.20
Paid unknown
Payout Ratio
36.4%
Sustainable
Loading dividend history...
Track Record
Frequency
Unknown
Payback Period
26.9 yr
Years to recoup investment via dividends alone
Upcoming
Ex-Dividend Date
Jun 17, 2025
Screen for dividend patterns
Find other stocks with similar dividend characteristics in the screener.